doi: 10.1007/BF01314051.
Modulation of human colonic arachidonic acid metabolism by sulfasalazine
- PMID: 2866075
- DOI: 10.1007/BF01314051
Item in Clipboard
Modulation of human colonic arachidonic acid metabolism by sulfasalazine
Dig Dis Sci.
1985 Dec.
Abstract
The effects of sulfasalazine and its moieties on synthesis of individual products of arachidonic acid metabolism by human colonic mucosa have been investigated. Sulfasalazine inhibited synthesis of the lipoxygenase products. Sulfasalazine and sulfapyridine also inhibited synthesis of thromboxane B2 while enhancing synthesis of prostaglandin (PG) F2 alpha or PGE2, respectively. Inhibition of synthesis of lipoxygenase products and modulation of the profile of cyclooxygenase products could reduce inflammation and enhance mucosal resistance to damage in ulcerative colitis.
Similar articles
-
Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.Eur J Pharmacol. 1989 Oct 10;169(2-3):225-34. doi: 10.1016/0014-2999(89)90019-8. Eur J Pharmacol. 1989. PMID: 2572437
-
Influence of sulfasalazine, 5-aminosalicylic acid and sulfapyridine on prostanoid synthesis and metabolism in rabbit colonic mucosa.Prostaglandins. 1985 Jan;29(1):133-42. doi: 10.1016/0090-6980(85)90158-3. Prostaglandins. 1985. PMID: 2858116
-
Inhibition of platelet thromboxane synthetase by sulfasalazine.Biochem Pharmacol. 1983 Jul 15;32(14):2205-9. doi: 10.1016/0006-2952(83)90227-7. Biochem Pharmacol. 1983. PMID: 6135423
-
Sulfasalazine. Multiplicity of action.Dig Dis Sci. 1992 Jun;37(6):801-12. doi: 10.1007/BF01300376. Dig Dis Sci. 1992. PMID: 1350243 Review. No abstract available.
-
Effects of mesalazine on the formation of lipoxygenase and cyclooxygenase products.Adv Exp Med Biol. 1995;371B:1301-6. Adv Exp Med Biol. 1995. PMID: 7502805 Review. No abstract available.
Cited by
-
Possible mode of action of 5-aminosalicylic acid.Dig Dis Sci. 1987 Dec;32(12 Suppl):51S-56S. doi: 10.1007/BF01312464. Dig Dis Sci. 1987. PMID: 2891468
-
Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: a randomised double blind trial.Gut. 1989 Oct;30(10):1354-61. doi: 10.1136/gut.30.10.1354. Gut. 1989. PMID: 2684804 Free PMC article. Clinical Trial.
-
Ulcerative colitis: current treatment strategies and future prospects.Therap Adv Gastroenterol. 2009 Mar;2(2):99-108. doi: 10.1177/1756283X09102329. Therap Adv Gastroenterol. 2009. PMID: 21180538 Free PMC article.
-
Oral 4-aminosalicylic acid versus 5-aminosalicylic acid slow release tablets. Double blind, controlled pilot study in the maintenance treatment of Crohn's ileocolitis.Gut. 1994 Aug;35(8):1081-5. doi: 10.1136/gut.35.8.1081. Gut. 1994. PMID: 7926910 Free PMC article. Clinical Trial.
-
Distinct kinetics in the frequency of peripheral CD4+ T cells in patients with ulcerative colitis experiencing a flare during treatment with mesalazine or with a herbal preparation of myrrh, chamomile, and coffee charcoal.PLoS One. 2014 Aug 21;9(8):e104257. doi: 10.1371/journal.pone.0104257. eCollection 2014. PLoS One. 2014. PMID: 25144293 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases
Miscellaneous